Related Experiment Videos
Use of DNA estimation for growth assessment in normal and hypoplastic fetal lungs
Insights
Human fetal lung development, measured by DNA content, shows a critical growth period in the early second trimester. Lung hypoplasia is linked to significantly reduced DNA levels, indicating impaired lung growth.
Area of Science:
- Developmental Biology
- Pediatric Pulmonology
- Fetal Medicine
Background:
- Human fetal lung growth is a complex process influenced by various factors.
- Understanding normal lung development is crucial for identifying and managing congenital lung abnormalities.
Purpose of the Study:
- To estimate total DNA in fetal and newborn lungs across gestation.
- To correlate lung DNA content with gestational age, body weight, and lung hypoplasia.
Main Methods:
- Total DNA was quantified in lung tissue samples from 80 fetuses and newborns (14 weeks gestation to term).
- Lung DNA levels were analyzed in relation to gestational age, body weight, and specific conditions like lung hypoplasia and urinary obstruction.
Main Results:
- Total lung DNA increased linearly with gestational age in appropriate-weight fetuses.
- Immature fetuses had higher DNA relative to body weight; small-for-dates infants showed reduced DNA levels.
- Lung hypoplasia, particularly with fetal anuria, was associated with significantly lower lung DNA content, resembling much earlier gestational ages.
Conclusions:
- The early second trimester represents a critical window for human fetal lung growth.
- Lung DNA content serves as a reliable indicator of fetal lung development and can identify impaired growth in conditions like lung hypoplasia.
Abstract:
Total DNA was estimated in the lungs of 80 fetuses and newborn infants varying in gestation from 14 weeks to term. In fetuses of appropriate weight for gestational age total lung DNA increased at a constant rate from about 35 mg at 17 weeks' gestation to 480 mg at term. The lungs of immature fetuses were heavier and contained more DNA relative to body weight than did those of mature infants. Small-for-dates infants had lower lung DNA levels for gestation than infants with weights appropriate for gestational age, but there was no difference when lung DNA was corrected for body weight. Lung hypoplasia defined in terms of lung/body weight ratio was associated with low lung DNA content for gestation, even when corrected for body weight. The total lung DNA at 34-40 weeks' gestation in infants with lung hypoplasia associated with fetal anuria or urinary outflow obstruction was equivalent to that seen in normal fetuses at 20-22 weeks' gestation. We conclude that the early second trimester is a critical period for human fetal lung growth.